216 related articles for article (PubMed ID: 29934293)
1. Mechanism of APTX nicked DNA sensing and pleiotropic inactivation in neurodegenerative disease.
Tumbale P; Schellenberg MJ; Mueller GA; Fairweather E; Watson M; Little JN; Krahn J; Waddell I; London RE; Williams RS
EMBO J; 2018 Jul; 37(14):. PubMed ID: 29934293
[TBL] [Abstract][Full Text] [Related]
2. Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease.
Tumbale P; Appel CD; Kraehenbuehl R; Robertson PD; Williams JS; Krahn J; Ahel I; Williams RS
Nat Struct Mol Biol; 2011 Oct; 18(11):1189-95. PubMed ID: 21984210
[TBL] [Abstract][Full Text] [Related]
3. Molecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease.
Schellenberg MJ; Tumbale PP; Williams RS
Prog Biophys Mol Biol; 2015 Mar; 117(2-3):157-165. PubMed ID: 25637650
[TBL] [Abstract][Full Text] [Related]
4. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity.
Tumbale P; Williams JS; Schellenberg MJ; Kunkel TA; Williams RS
Nature; 2014 Feb; 506(7486):111-5. PubMed ID: 24362567
[TBL] [Abstract][Full Text] [Related]
5. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia/ataxia with oculomotor apraxia 1.
Tada M; Yokoseki A; Sato T; Makifuchi T; Onodera O
Adv Exp Med Biol; 2010; 685():21-33. PubMed ID: 20687492
[TBL] [Abstract][Full Text] [Related]
6. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates.
Ahel I; Rass U; El-Khamisy SF; Katyal S; Clements PM; McKinnon PJ; Caldecott KW; West SC
Nature; 2006 Oct; 443(7112):713-6. PubMed ID: 16964241
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of DNA deadenylation by the neurological disease protein aprataxin.
Rass U; Ahel I; West SC
J Biol Chem; 2008 Dec; 283(49):33994-4001. PubMed ID: 18836178
[TBL] [Abstract][Full Text] [Related]
8. DNA single-strand break repair is impaired in aprataxin-related ataxia.
Hirano M; Yamamoto A; Mori T; Lan L; Iwamoto TA; Aoki M; Shimada K; Furiya Y; Kariya S; Asai H; Yasui A; Nishiwaki T; Imoto K; Kobayashi N; Kiriyama T; Nagata T; Konishi N; Itoyama Y; Ueno S
Ann Neurol; 2007 Feb; 61(2):162-74. PubMed ID: 17315206
[TBL] [Abstract][Full Text] [Related]
9. A novel nonsense mutation in the APTX gene associated with delayed DNA single-strand break removal fails to enhance sensitivity to different genotoxic agents.
Crimella C; Cantoni O; Guidarelli A; Vantaggiato C; Martinuzzi A; Fiorani M; Azzolini C; Orso G; Bresolin N; Bassi MT
Hum Mutat; 2011 Apr; 32(4):E2118-33. PubMed ID: 21412945
[TBL] [Abstract][Full Text] [Related]
10. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin.
El-Khamisy SF; Katyal S; Patel P; Ju L; McKinnon PJ; Caldecott KW
DNA Repair (Amst); 2009 Jun; 8(6):760-6. PubMed ID: 19303373
[TBL] [Abstract][Full Text] [Related]
11. Short-patch single-strand break repair in ataxia oculomotor apraxia-1.
Reynolds JJ; El-Khamisy SF; Caldecott KW
Biochem Soc Trans; 2009 Jun; 37(Pt 3):577-81. PubMed ID: 19442253
[TBL] [Abstract][Full Text] [Related]
12. The DNA repair enzyme, aprataxin, plays a role in innate immune signaling.
Madsen HB; Pease LI; Scanlan RL; Akbari M; Rasmussen LJ; Shanley DP; Bohr VA
Front Aging Neurosci; 2023; 15():1290681. PubMed ID: 38161589
[TBL] [Abstract][Full Text] [Related]
13. Ribonucleotide triggered DNA damage and RNA-DNA damage responses.
Wallace BD; Williams RS
RNA Biol; 2014; 11(11):1340-6. PubMed ID: 25692233
[TBL] [Abstract][Full Text] [Related]
14. Ataxia with Ocular Apraxia Type 1 (AOA1) (APTX, W279* Mutation): Neurological, Neuropsychological, and Molecular Outlining of a Heterogenous Phenotype in Four Colombian Siblings.
Aguillon D; Vasquez D; Madrigal L; Moreno S; Hernández D; Isaza-Ruget M; Lopez JJ; Landires I; Nuñez-Samudio V; Restrepo CM; Vidal OM; Vélez JI; Arcos-Holzinger M; Lopera F; Arcos-Burgos M
Mol Neurobiol; 2022 Jun; 59(6):3845-3858. PubMed ID: 35420381
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.
Renaud M; Moreira MC; Ben Monga B; Rodriguez D; Debs R; Charles P; Chaouch M; Ferrat F; Laurencin C; Vercueil L; Mallaret M; M'Zahem A; Pacha LA; Tazir M; Tilikete C; Ollagnon E; Ochsner F; Kuntzer T; Jung HH; Beis JM; Netter JC; Djamshidian A; Bower M; Bottani A; Walsh R; Murphy S; Reiley T; Bieth É; Roelens F; Poll-The BT; Lourenço CM; Jardim LB; Straussberg R; Landrieu P; Roze E; Thobois S; Pouget J; Guissart C; Goizet C; Dürr A; Tranchant C; Koenig M; Anheim M
JAMA Neurol; 2018 Apr; 75(4):495-502. PubMed ID: 29356829
[TBL] [Abstract][Full Text] [Related]
16. Complementation of aprataxin deficiency by base excision repair enzymes.
Çağlayan M; Horton JK; Prasad R; Wilson SH
Nucleic Acids Res; 2015 Feb; 43(4):2271-81. PubMed ID: 25662216
[TBL] [Abstract][Full Text] [Related]
17. The FHA domain of aprataxin interacts with the C-terminal region of XRCC1.
Date H; Igarashi S; Sano Y; Takahashi T; Takahashi T; Takano H; Tsuji S; Nishizawa M; Onodera O
Biochem Biophys Res Commun; 2004 Dec; 325(4):1279-85. PubMed ID: 15555565
[TBL] [Abstract][Full Text] [Related]
18. APTX acts in DNA double-strand break repair in a manner distinct from XRCC4.
Imamura R; Saito M; Shimada M; Kobayashi J; Ishiai M; Matsumoto Y
J Radiat Res; 2023 May; 64(3):485-495. PubMed ID: 36940705
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
[TBL] [Abstract][Full Text] [Related]
20. Defective DNA repair and neurodegenerative disease.
Rass U; Ahel I; West SC
Cell; 2007 Sep; 130(6):991-1004. PubMed ID: 17889645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
